Your browser doesn't support javascript.
loading
Anti-NMDAr Encephalitis and COVID-19 in a Patient With Systemic pANCA-Vasculitis and Recurrent Varicella Zoster Infection.
Moura, João; Duarte, Sara; Sardoeira, Ana; Neves-Maia, João; Damásio, Joana; Taipa, Ricardo; Carneiro, Paula; Neves, Esmeralda; Campar, Ana; Santos, Ernestina.
Afiliação
  • Moura J; Department of Neurology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Duarte S; Department of Neurology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Sardoeira A; Department of Neurology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Neves-Maia J; Department of Internal Medicine, Centro Hospitalar Unniversitário do Porto, Porto, Portugal.
  • Damásio J; Department of Neurology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Taipa R; Unit for Multidisciplinary Research in Biomedicine (UMIB), Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Porto, Portugal.
  • Carneiro P; Department of Neurology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Neves E; Unit for Multidisciplinary Research in Biomedicine (UMIB), Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Porto, Portugal.
  • Campar A; Neuropathology Unit, Department of Neurosciences, Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Santos E; Immunology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Neurohospitalist ; 12(2): 383-387, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35401915
ABSTRACT

Introduction:

There is a complex interplay between systemic autoimmunity, immunosuppression, and infections. Any or all of these can result in neurologic manifestations, requiring diligence on the part of neurologists. Case report We herein report a case of a patient on immunosuppressive treatment for a vasculitis that resulted in zoster meningoencephalitis. This was further complicated by the development of anti-NMDAr encephalitis, the etiology of which is undetermined and further discussed in this paper. The patient eventually developed COVID-19 during hospitalization, succumbing to the respiratory infection.

Conclusion:

This case emphasizes that post-infectious autoimmune disorders are becoming increasingly recognized and that they should still be considered in patients who are on immunosuppression. Practitioners should be aware of the complex relationship between autoimmunity and immunosuppression and consider both throughout the disease course.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article